KORU Medical Systems 表示,展望2026年剩余时光,公司国际核心业务的增长步伐预计将趋于温和。这一预期背后,是企业在特定欧洲市场需审慎应对区域性的产品上市节奏与复杂动态。
KORU Medical Systems 表示,展望2026年剩余时光,公司国际核心业务的增长步伐预计将趋于温和。这一预期背后,是企业在特定欧洲市场需审慎应对区域性的产品上市节奏与复杂动态。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.